Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients

Journal of the Neurological Sciences

Volumn 121, Issue 1, 1994, Pages 46-49

  Kuiper, Michael A ^a   Visser, Jelle J ^a   Bergmans, Paul L M ^a   Scheltens, Philip ^a   Wolters, Erik C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Biopterin; Cerebrospinal fluid; Multiple system atrophy; Neurodegeneration; Nitrate; Nitric oxide; Nitrite; Parkinson's disease

Indexed keywords

NITRATE; NITRIC OXIDE; NITRITE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; PARKINSON DISEASE; PRIORITY JOURNAL; SHY DRAGER SYNDROME;

AGED; ALZHEIMER DISEASE; ATROPHY; DEMENTIA; FEMALE; HUMAN; MALE; MIDDLE AGE; NERVE DEGENERATION; NERVOUS SYSTEM DISEASES; NITRATES; NITRITES; PARKINSON DISEASE;

EID: 0028153979     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-510X(94)90155-4     Document Type: Article

References (25)

1. Tetrahydrobiopterin metabolism in the temporal lobe of patients dying with senile dementia of Alzheimer type
2. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death
3. Localization of nitric oxide synthase indicating a neural role for nitric oxide
4. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism
5. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures
6. A novel neuronal messenger molecule in brain: the free radical, nitric oxide
7. 15N)nitrate in biological fluids
8. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase
9. Macrophage nitric oxide synthase: relationship between enzyme-bound tetrahydrobiopterin and synthase activity
10. Macrophage cytotoxicity: role for l-arginine deiminase and imino nitrogen oxidation to nitrite
11. l-Arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells
12. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study
13. Stimulation of human nitric oxide synthase by tetrahydrobiopterin and selective binding of the cofactor
14. CSF biopterin and neopterin levels in Parkinson's disease patients
15. Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease
16. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
17. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
18. Endothelium derived relaxing factor
19. Nitric oxide: physiology, pathophysiology, and pharmacology
20. Biopterin in human brain and urine from controls and parkinsonian patients: application of a new radioimmunoassay
21. Multiple system atrophy-the nature of the beast
22. Expression of immune system-associated antigens by cells of the central nervous system: relationship to the pathology of Alzheimer's disease
23. 123I-iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism
24. Nitric oxide as neuronal messenger